
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
SAS’ next-generation solutions for clinical trial data analysis and real world evidence debuted at PhUSE EU Connect in Frankfurt, Germany. This debut introduced SAS Life Science Analytics Framework and SAS Real World Evidence to help improve the development and safety of new pharmaceuticals with artificial intelligence.
Read the full release






